THE INFLUENCE OF POLYMER GLASS-TRANSITION TEMPERATURE AND MOLECULAR-WEIGHT ON DRUG RELEASE FROM TABLETS CONTAINING POLY(DL-LACTIC ACID)

被引:119
作者
OMELCZUK, MO [1 ]
MCGINITY, JW [1 ]
机构
[1] UNIV TEXAS,COLL PHARM,INST DRUG DYNAM,AUSTIN,TX 78712
关键词
POLY(DL-LACTIC ACID); GLASS TRANSITION TEMPERATURE; MOLECULAR WEIGHT; DYNAMIC MECHANICAL THERMAL ANALYSIS; MATRIX TABLETS; TABLETTING INDEXES;
D O I
10.1023/A:1018967424392
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Five molecular weight grades of poly(DL-lactic acid) were characterized using gel permeation chromatography, differential scanning calorimetry, and viscometry to determine the effect of molecular weight on the glass transition temperature and the intrinsic viscosity. In addition, dynamic mechanical thermal analysis was used to assess the dynamic storage modulus and the damping factor of the polymer samples by detecting motional and structural transitions over a wide temperature range. Significant relationships were found between the molecular weight and these polymer properties. The five grades of poly(DL-lactic acid) were also incorporated as binders into matrix tablet formulations containing the model drug theophylline and microcrystalline cellulose. Dissolution studies showed significant correlations between the properties of the polymer and the matrix release profiles of the tablets. The release of theophylline slowed down progressively as the polymer molecular weight increased. The differences in release became less significant and reached a limiting asymptotic value as the molecular weight increased to 138,000. Further, tablet index testing was utilized to determine the compaction properties of the polymer granulations. Although there was no correlation with the molecular weight of PLA, brittle fracture index testing indicated very low brittleness for all granulations tested. However, bonding index determinations correlated very well with both the physical-mechanical properties of the polymer and drug release profiles.
引用
收藏
页码:26 / 32
页数:7
相关论文
共 30 条
[1]  
AK Schneider, 1972, [US Patent, 3, 636, 956], Patent No. [3,636,956, 3636956]
[2]  
BILLMEYER FW, 1977, INTRO POLYM SCI TECH, P184
[3]  
Billmeyer Jr FW, 1984, TXB POLYM SCI, P208
[4]  
COFFIN M, 1992, IN PRESS PHARM RES
[5]   CONTROLLED DELIVERY SYSTEMS FOR PROTEINS BASED ON POLY(LACTIC GLYCOLIC ACID) MICROSPHERES [J].
COHEN, S ;
YOSHIOKA, T ;
LUCARELLI, M ;
HWANG, LH ;
LANGER, R .
PHARMACEUTICAL RESEARCH, 1991, 8 (06) :713-720
[6]  
Eisenberg, 1984, PHYSICAL PROPERTIES, P55
[7]  
FIACHIONEN EM, 1944, IND ENG CHEM, V36, P223
[8]  
GOODMAN M, 1977, INTRO POLYM SCI TECH, P25
[9]  
HEISTAND E, 1984, POWER TECHNOL, V38, P145
[10]  
HEISTAND EN, 1985, J PHARM SCI, V74, P768